Blood Advances | 2025
Impact of post-transplant cyclophosphamide-based GVHD prophylaxis in patients 70 years and older: An update from BMT CTN 1703.
Abedin SM, Martens MJ, Bolanos-Meade J, Al Malki MM, Lian Q, Runaas L, Elmariah H, Gooptu M, Larkin KT, Shaffer BC, Loren AW, Solh MM, Alousi AM, Jamy O, Perales MA, Rezvani AR, Bhatt AS, El Jurdi N, Yao JM, Applegate K, Kean LS, Efebera YA, Reshef R, Clark WB, Leifer E, Saber W, Horowitz MM, Jones RJ, Holtan SG, Hamadani M
PubMed
PMID: 40305657
Abstract
Related Articles
CIBMTR Study #: 1703